About
Anastasis' technology relates to a novel treatment applicable to many cancers. These cancers depend on rogue cells multiplying uncontrollably caused by DNA abnormalities (mutations) in important pathways involved in the generation of cancer and cancer stem cells. When there are mutations in these pathways, cancer cells and cancer stem cells, run rogue, multiply and spread uncontrollably.
- United Kingdom
- Legal Name: AnAStASis Biotec Limited
- Company ID: 10502511
- Year Founded: —
- Industry: Biotechnology
- Website: https://anastasisbiotec.com/
Highlights
£28.1M
CF Valuation
£0
Total Raised
—
Revenue
—
Employees
Indicators
Profit Margin
—
—
Current Ratio
—
—
Revenue Growth
No data available
